[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361266-105":59,"doc-detail-361266-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-ras-drives-eed-degradation-and-prc2-dysfunction-to-promote-aggressive-squamous-cell-carcinoma","Oncogenic Ras drives EED degradation and PRC2 dysfunction to promote aggressive squamous cell carcinoma","","Squamous cell carcinomas frequently show EZH2 upregulation, yet PRC2 activity in SCC pathogenesis is unclear. This study reveals a paradox: despite elevated EZH2, PRC2-catalyzed H3K27me3 is markedly reduced in human SCC and matching mouse models. Mechanistically, oncogenic Ras signaling triggers degradation of the PRC2 subunit EED, destabilizing PRC2 and depleting H3K27me3. EED loss reprograms keratinocytes into an aggressive tumor-specific state and induces paracrine changes that remodel the tumor microenvironment to drive metastasis. Restoring EED suppresses growth by reconstituting PRC2 integrity and H3K27me3 levels.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-ras-drives-eed-degradation-and-prc2-dysfunction-to-promote-aggressive-squamous-cell-carcinoma/361266/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-ras-drives-eed-degradation-and-prc2-dysfunction-to-promote-aggressive-squamous-cell-carcinoma/361266.png","ImageObject",300,407,{"name":92,"@type":93},"RuangKosong","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What paradox does the study find regarding EZH2 and PRC2 activity in SCC?","Question",{"text":112,"@type":113},"EZH2 is elevated in SCC, but PRC2-catalyzed H3K27me3 is profoundly reduced in human SCC and complementary mouse models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does oncogenic Ras contribute to PRC2 dysfunction?",{"text":117,"@type":113},"Oncogenic Ras signaling causes degradation of the PRC2 subunit EED, destabilizing PRC2 and depleting H3K27me3.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens when EED is reintroduced in the tumor models?",{"text":121,"@type":113},"Reintroducing EED suppresses tumor growth by restoring PRC2 integrity and H3K27me3 levels, demonstrating that the epigenetic collapse can be reversed.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361266,1790811384,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article [https://doi.org/10.1038/s41467-026-75529-0](https://doi.org/10.1038/s41467-026-75529-0)  \nOncogenic Ras drives EED degradation and PRC2 dysfunction to promote aggressive squamous cell carcinoma  \nReceived: 8 October 2025  \n\n| Accepted: 2 July 2026 |\n| --- |\n| |\n| Check for updates |\n\nMeng-Yen Li1, Aubrey Houser 2,3, Pradeep Cheema 4, Xiang Yu Zheng 5, Paula Restrepo2,3, Pooja Flora1,11, Yudong Zhou 1,12, Gil Segal-Dalal6,  \nEldad Silberstein7, Xiaotao Zhang 8, Markus Schober 4, Deyou Zheng 5,9,10, Idan Cohen 6, Andrew L. Ji 2,3 & Elena Ezhkova 1   \nSquamous cell carcinomas (SCCs) are common epithelial malignancies frequently associated with EZH2 upregulation, which correlates with aggressive growth and poor prognosis. EZH2 functions as the catalytic subunit of Polycomb repressive complex 2 (PRC2), which deposits the repressive H3K27me3 histone mark, yet PRC2 function in SCC pathogenesis remains unresolved. Here, we uncover a paradox: although EZH2 is elevated, the PRC2-catalyzed H3K27me3 is profoundly reduced in human SCC and complementary murine models. Mechanistically, we identify that oncogenic Ras signaling causes degradation of the PRC2 subunit EED, destabilizing PRC2 and depleting H3K27me3. Loss of EED reprograms keratinocytes into an aggressive tumorspeciﬁc cell state and induces paracrine factors that remodel the tumor microenvironment, driving metastasis. Remarkably, reintroducing EED suppresses tumor growth via restoring PRC2 integrity and H3K27me3 levels, revealing the reversibility of this epigenetic collapse. These ﬁndings link oncogenic signaling to epigenetic reprogramming and uncover PRC2 reconstitution as a potential therapeutic option in epithelial cancers.  \nSquamous cell carcinoma (SCC) is a common malignancy that arises from stratiﬁed epithelial tissues, including the skin, head and neck, cervix, and lung1–5. Among these, cutaneous SCC (cSCC) is the second most prevalent form of non-melanoma skin cancer and originates from basal keratinocytes within the epidermis6,7. Following tumor initiation, cSCC progression involves local invasion of deep structures and regional  \nmetastasis via lymphatic invasion8. Aggressive or metastatic forms of cSCC pose signiﬁcant clinical challenges, with patients experiencing high mortality rates due to resistance to therapy9. However, the mechanism associated with aggressive progression is unclear. This underscores an unmet need to elucidate the molecular mechanisms underlying cSCC progression and develop therapeutic strategies against metastatic cSCC.  \n1Department of Stem Cell Biology and Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 2Department of Dermatology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4Ronald O. Perelman Department of Dermatology and Department of Cell Biology, NYU Grossman School of Medicine, New York, NY, USA. 5Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA. 6The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Science, Ben-Gurion University of the Negev, Beer Sheva, Israel. 7Department of Plastic Surgery, Soroka University Medical Center, Faculty of Health Science, Ben-Gurion University of the Negev, Beer Sheva, Israel. 8Division of Liver Diseases, Department of Medicine, Translational Epidemiology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 9Department of Neurology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA. 10Data Science Institute, Albert Einstein College of Medicine, Bronx, NY, USA. 11Present address: Department of Molecular, Cell and Systems Biology, University of California, Riverside, Riverside, CA, USA. 12Present address: Division of Medical  \nSciences, Harvard Medical School, Boston, MA, USA. e-mail: ","cbCainrnwM6KiCqq","https://ap.wps.com/l/cbCainrnwM6KiCqq","pdf",8928759,21,"English","# Background\n## EZH2 and PRC2 in SCC\n# Key discovery\n## Reduced PRC2 activity despite elevated EZH2\n# Mechanism\n## Ras signaling degrades EED\n# Biological impact\n## Tumor reprogramming and microenvironment remodeling\n# Therapeutic implication\n## EED reintroduction restores PRC2 and suppresses growth","[{\"question\":\"What paradox does the study find regarding EZH2 and PRC2 activity in SCC?\",\"answer\":\"EZH2 is elevated in SCC, but PRC2-catalyzed H3K27me3 is profoundly reduced in human SCC and complementary mouse models.\"},{\"question\":\"How does oncogenic Ras contribute to PRC2 dysfunction?\",\"answer\":\"Oncogenic Ras signaling causes degradation of the PRC2 subunit EED, destabilizing PRC2 and depleting H3K27me3.\"},{\"question\":\"What happens when EED is reintroduced in the tumor models?\",\"answer\":\"Reintroducing EED suppresses tumor growth by restoring PRC2 integrity and H3K27me3 levels, demonstrating that the epigenetic collapse can be reversed.\"}]","Oncogenic Ras drives EED degradation and PRC2 dysfunction to promote aggressive squamous cell carcinoma | PDF",1790143754,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2a2d188a91225d83b88a1867ef5414b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d93aa5500f0eea179fc70bf9bb55ccd.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0be7faf5dfa55c1555e89940777f1b0b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/402c45b59508086587e09b0cdc1cedbf.webp",980,1301]